We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTE icon
11476
PUT
Gran Tierra Energy
GTE
$325M
$82K ﹤0.01%
7,120
-420
-6% -$6.69K
NGNE icon
11477
Neurogene
NGNE
$723M
$82K ﹤0.01%
3,975
+2,958
+291% +$72.2K
RLGT icon
11478
PUT
Radiant Logistics
RLGT
$408M
$82K ﹤0.01%
11,100
-3,400
-23% -$21.9K
TISI icon
11479
Team
TISI
$101M
$82K ﹤0.01%
11,111
+9,257
+499% +$128K
TESS
11480
DELISTED
Tessco Technologies Inc
TESS
$82K ﹤0.01%
+13,894
New +$83.1K
AUS.WS
11481
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$82K ﹤0.01%
296,794
+114
+0% +$43
ACP
11482
abrdn Income Credit Strategies Fund
ACP
$645M
$81K ﹤0.01%
10,656
+543
+5% +$4.77K
DRIO icon
11483
PUT
DarioHealth
DRIO
$74.3M
$81K ﹤0.01%
660
-175
-21% -$20.5K
EGY icon
11484
PUT
Vaalco Energy
EGY
$608M
$81K ﹤0.01%
11,700
-23,100
-66% -$165K
MYPS icon
11485
PUT
PLAYSTUDIOS Inc
MYPS
$63.1M
$81K ﹤0.01%
18,900
+3,000
+19% +$16.3K
PLG
11486
PUT
Platinum Group Metals
PLG
$189M
$81K ﹤0.01%
61,500
-81,800
-57% -$141K
MRNS
11487
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$81K ﹤0.01%
16,750
-69,500
-81% -$423K
LGV.WS
11488
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$81K ﹤0.01%
626,400
+56,893
+10% +$15.9K
ATIP
11489
PUT
DELISTED
ATI Physical Therapy, Inc.
ATIP
$81K ﹤0.01%
1,154
-236
-17% -$20.9K
ASMB icon
11490
CALL
Assembly Biosciences
ASMB
$671M
$80K ﹤0.01%
3,175
+350
+12% +$8.05K
ENLV icon
11491
CALL
Enlivex Ltd
ENLV
$26.6M
$80K ﹤0.01%
+1,180
New +$91.4K
OTRK
11492
DELISTED
Ontrak
OTRK
$80K ﹤0.01%
+838
New +$117K
RBOT
11493
PUT
DELISTED
Vicarious Surgical
RBOT
$80K ﹤0.01%
910
-890
-49% -$109K
RETL icon
11494
PUT
Direxion Daily Retail Bull 3X ETF
RETL
$27.3M
$80K ﹤0.01%
+10,700
New +$144K
SPRO icon
11495
Spero Therapeutics
SPRO
$71.6M
$80K ﹤0.01%
108,351
+97,554
+904% +$284K
VRCA icon
11496
Verrica Pharmaceuticals
VRCA
$85.4M
$80K ﹤0.01%
4,151
+1,187
+40% +$59.7K
AIFU
11497
AIFU Inc
AIFU
$215M
$80K ﹤0.01%
39
-16
-29% -$36.9K
EXPR
11498
PUT
DELISTED
Express, Inc.
EXPR
$80K ﹤0.01%
2,050
-2,615
-56% -$157K
VISL
11499
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$80K ﹤0.01%
6,755
-1,105
-14% -$16.6K
CARM
11500
CALL
DELISTED
Carisma Therapeutics
CARM
$79K ﹤0.01%
4,880
+700
+17% +$8.01K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.